SleepImage joins the American Heart Association’s Center for Health Technology & Innovation’s Innovators’ Network, which is focused on building and fostering health tech relationships to develop innovative and scalable solutions. SleepImage is a technology company offering FDA-cleared cloud-based software as a medical device based on analyzing data collected with a single sensor to evaluate sleep quality and diagnose and manage sleep disorders.

“It is a milestone for SleepImage to join the American Heart Association’s Center for Health Technology & Innovation’s Network at a time when public health is under pressure and healthcare systems are looking for ways to improve outcomes at reduced cost,” says Bogi Palsson, CEO of SleepImage, in a release.

[RELATED: Severe Obstructive Sleep Apnea Has Grave Consequences for Heart Health]

Patrick Wayte, senior vice president of the American Heart Association’s Center for Health Technology & Innovation, says in a release, “The Center aims to expand usage of the association’s science-based CarePlans, so it’s incredibly encouraging to see SleepImage leveraging best-in-class science from the American Heart Association with the aim of improving health education and engagement.”

Preliminary findings in the journal Circulation state, “The incorporation of sleep as a metric of CVH, akin to other health behaviors, may improve CVD risk prediction.”

A research paper in the Journal of Hypertension demonstrates how improving the SleepImage Sleep Quality Index (SQI) significantly improves blood pressure, even while awake, in patients with obstructive sleep apnea.

“The American Heart Association is pleased to explore the promise of managed sleep health as part of its efforts to improve cardiovascular health and mitigate risk of cardiovascular disease with timely therapeutic interventions,” says Wayte.